ATE170401T1 - Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände - Google Patents
Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zuständeInfo
- Publication number
- ATE170401T1 ATE170401T1 AT92909629T AT92909629T ATE170401T1 AT E170401 T1 ATE170401 T1 AT E170401T1 AT 92909629 T AT92909629 T AT 92909629T AT 92909629 T AT92909629 T AT 92909629T AT E170401 T1 ATE170401 T1 AT E170401T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- compositions
- hypoglycemia
- diabetes mellitus
- medical conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/670,231 US5264372A (en) | 1991-03-15 | 1991-03-15 | Receptor-based screening methods for amylin agonists and antagonists |
US70499591A | 1991-05-24 | 1991-05-24 | |
US07/774,411 US5321008A (en) | 1991-01-10 | 1991-10-10 | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE170401T1 true ATE170401T1 (de) | 1998-09-15 |
Family
ID=27418205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92909629T ATE170401T1 (de) | 1991-03-15 | 1992-03-13 | Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände |
Country Status (11)
Country | Link |
---|---|
US (2) | US5321008A (de) |
EP (1) | EP0533898B1 (de) |
JP (1) | JPH05507943A (de) |
AT (1) | ATE170401T1 (de) |
AU (1) | AU648895B2 (de) |
CA (1) | CA2082928C (de) |
DE (1) | DE69226835T2 (de) |
DK (1) | DK0533898T3 (de) |
ES (1) | ES2122995T3 (de) |
MX (1) | MX9201110A (de) |
WO (1) | WO1992016222A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
DE69221040T2 (de) * | 1991-01-10 | 1997-11-13 | Amylin Pharmaceuticals Inc | Aktivätsmessungen des amylin |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
US5814600A (en) * | 1991-05-24 | 1998-09-29 | Amylin Pharmaceuticals Inc. | Method and composition for treatment of insulin requiring mammals |
US5739106A (en) * | 1995-06-07 | 1998-04-14 | Rink; Timothy J. | Appetite regulating compositions |
US6143718A (en) | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
US7312196B2 (en) * | 1997-01-08 | 2007-12-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US6410511B2 (en) | 1997-01-08 | 2002-06-25 | Amylin Pharmaceuticals, Inc. | Formulations for amylin agonist peptides |
US7101853B2 (en) * | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
US5929055A (en) * | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
DK1044015T3 (da) * | 1998-01-09 | 2008-12-08 | Amylin Pharmaceuticals Inc | Formuleringer med amylinagonistpeptider og insulin |
JP4372345B2 (ja) | 1998-02-13 | 2009-11-25 | アミリン・ファーマシューティカルズ,インコーポレイテッド | 新規な混合アミリン活性化合物 |
US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
MXPA03003815A (es) * | 2000-10-26 | 2004-08-12 | Johnson & Johnson | Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos. |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
NZ541365A (en) * | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
US7812120B2 (en) | 2003-03-21 | 2010-10-12 | Par Pharmaceutical, Inc. | Nasal calcitonin formulations containing chlorobutanol |
CA2571030A1 (en) * | 2004-06-29 | 2006-01-12 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
JP2011525895A (ja) * | 2008-06-25 | 2011-09-29 | ノボ・ノルデイスク・エー/エス | アミリン及びサケカルシトニンの誘導体化ハイブリッドペプチド |
EP2762150A1 (de) * | 2009-03-12 | 2014-08-06 | Nordic Bioscience A/S | Behandlung von Diabetes und Stoffwechselsyndrom |
CN117653715A (zh) | 2017-02-03 | 2024-03-08 | 范德比尔特大学 | 用于治疗糖尿病的系统、组合物和方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3171774D1 (en) * | 1980-03-31 | 1985-09-19 | Teijin Ltd | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
AU631112B2 (en) * | 1988-01-11 | 1992-11-19 | Amylin Corporation | Treatment of type 2 diabetes mellitus |
AU620727B2 (en) * | 1989-07-10 | 1992-02-20 | Amylin Pharmaceuticals, Inc. | Treatment of obesity and essential hypertension and related disorders |
-
1991
- 1991-10-10 US US07/774,411 patent/US5321008A/en not_active Ceased
-
1992
- 1992-03-13 AU AU16873/92A patent/AU648895B2/en not_active Ceased
- 1992-03-13 JP JP92509074A patent/JPH05507943A/ja active Pending
- 1992-03-13 DE DE69226835T patent/DE69226835T2/de not_active Expired - Fee Related
- 1992-03-13 ES ES92909629T patent/ES2122995T3/es not_active Expired - Lifetime
- 1992-03-13 MX MX9201110A patent/MX9201110A/es unknown
- 1992-03-13 CA CA002082928A patent/CA2082928C/en not_active Expired - Fee Related
- 1992-03-13 DK DK92909629T patent/DK0533898T3/da active
- 1992-03-13 WO PCT/US1992/002191 patent/WO1992016222A1/en active IP Right Grant
- 1992-03-13 EP EP92909629A patent/EP0533898B1/de not_active Expired - Lifetime
- 1992-03-13 AT AT92909629T patent/ATE170401T1/de not_active IP Right Cessation
-
1994
- 1994-06-10 US US08/259,755 patent/US5508260A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5508260A (en) | 1996-04-16 |
US5321008A (en) | 1994-06-14 |
DE69226835D1 (de) | 1998-10-08 |
CA2082928A1 (en) | 1992-09-16 |
ES2122995T3 (es) | 1999-01-01 |
MX9201110A (es) | 1993-07-01 |
EP0533898A1 (de) | 1993-03-31 |
WO1992016222A1 (en) | 1992-10-01 |
DK0533898T3 (da) | 1999-05-31 |
EP0533898B1 (de) | 1998-09-02 |
CA2082928C (en) | 2000-09-05 |
AU1687392A (en) | 1992-10-21 |
JPH05507943A (ja) | 1993-11-11 |
AU648895B2 (en) | 1994-05-05 |
DE69226835T2 (de) | 1999-01-14 |
EP0533898A4 (en) | 1993-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE170401T1 (de) | Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände | |
ATE194918T1 (de) | Behandlung von diabetes | |
NO940180D0 (no) | Anvendelse av IGF-I | |
SI0699686T1 (en) | Biologically active fragments of glucagon-like insulinotropic peptide | |
HUP9700368A2 (hu) | II-típusú diabetes mellitus kezelése amilin agonistákkal | |
DE69133595D1 (de) | Verfahren zur langfristigen Reduktion von Körperfettspeichern, Insulinresistenz, Hyperinsulinämie und Hyperglykämie in Vertebraten | |
DE68929217D1 (en) | Insulinotropes hormon | |
DE69132688T2 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
EA200000748A1 (ru) | Способ введения мономерных аналогов инсулина | |
FI952536A0 (fi) | Glukagonia muistuttavia insulinotrooppisia komplekGlukagonia muistuttavia insulinotrooppisia komplekseja, koostumuksia ja menetelmiä seja, koostumuksia ja menetelmiä | |
EA200000041A1 (ru) | Способ лечения диабета тиазолидиндионом и метформином | |
DE69100282T3 (de) | Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie. | |
EP0766966A3 (de) | Methode zur Behandlung der Insulinresistenz | |
SK42395A3 (en) | Pharmaceutical agent for treatment or prevention of insulin-dependent diabetes mellitus, a method of producing and use thereof | |
ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
ATE192656T1 (de) | Verfahren zur behandlung von patienten mit chronischer lebererkrankung | |
DE69305091D1 (de) | Methode zur behandlung oder verhütung von fettleibigkeit | |
ATE484293T1 (de) | Verfahren zur vorbeugung oder behandlung von diabetes | |
Pickup et al. | Intensive insulin pump therapy slightly improves glycemic control in type 1 diabetes/Commentary | |
DE69218544D1 (de) | Verwendung von BMY 14802 zur Behandlung von Angstzuständen bei Patienten mit Benzodiazepin-Entzugserscheinungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |